SCHEMBL2187253

SCHEMBL2187253

CCOc1cccc(CCNC(=O)c2coc(CNC(=O)COc3ccc(OC(F)(F)F)cc3)n2)c1.O=C(COc1ccc(OC(F)(F)F)cc1)NCc1nc(C(=O)NCCc2ccc(Br)cc2)co1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SGMS1 Q86VZ5 2/20 0.42
TP53 P04637 2/20 0.41
CACNA1G O43497 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNA1I Q9P0X4 1/20 0.41
MAPT P10636 3/20 0.40
TRPV1 Q8NER1 2/20 0.40
LTA4H P09960 1/20 0.39
EPHX2 P34913 1/20 0.39
KMT2A Q03164 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAF1 P04049 1/20 0.38
PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668410 0.85 LTA4H (0.48) SGMS1CACNA1GCACNA1HCACNA1IMAPT
SCHEMBL5670058 0.84 TRPV1 (0.45) SGMS1CACNA1GCACNA1HCACNA1IMAPT
SCHEMBL2171605 0.84 TRPV1 (0.58) SGMS1TP53CACNA1GCACNA1HCACNA1I
SCHEMBL5667686 0.83 CACNA1G (0.46) CACNA1GCACNA1HCACNA1IMAPTTRPV1
SCHEMBL4387708 0.80 TRPV1 (0.44) TP53MAPTTRPV1CA1CA2
SCHEMBL2171492 0.78 TRPV1 (0.56) CACNA1GCACNA1HCACNA1ITRPV1KMT2A
SCHEMBL5669931 0.75 ALDH1A1 (0.52) CACNA1GCACNA1HCACNA1IMAPTKMT2A
SCHEMBL4392401 0.74 CACNA1G (0.51) CACNA1GCACNA1HCACNA1ITRPV1EPHX2
SCHEMBL2172285 0.73 CACNA1G (0.45) CACNA1GCACNA1HCACNA1IKMT2ARAB9A
SCHEMBL12407146 0.73 CACNA1G (0.48) CACNA1GCACNA1HCACNA1ITRPV1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US claimed